MedPath
HSA Approval

MOMETASONE NTC NASAL SPRAY SUSPENSION 50 MCG/ACTUATION

SIN15434P

MOMETASONE NTC NASAL SPRAY SUSPENSION 50 MCG/ACTUATION

MOMETASONE NTC NASAL SPRAY SUSPENSION 50 MCG/ACTUATION

February 26, 2018

NOVEM HEALTHCARE PTE LTD

NOVEM HEALTHCARE PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantNOVEM HEALTHCARE PTE LTD
Licence HolderNOVEM HEALTHCARE PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

SPRAY, SUSPENSION

NASAL

Medical Information

R01AD09

mometasone

Manufacturer Information

NOVEM HEALTHCARE PTE LTD

Mipharm S.p.A

Active Ingredients

Mometasone furoate monohydrate 51.7mcg equivalent to Mometasone furoate

50mcg/actuation

Mometasone

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.